Phibro Animal Health | PAHC - Debt


Phibro Animal Health reported $474.17M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Align Technology USD 116.04M 1.6M Mar/2026
ANI Pharmaceuticals USD 613.76M 3.28M Mar/2026
Aurora Cannabis CAD 23.86M 76.48M Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Canopy Growth CAD 278.71M 19.38M Mar/2026
Corcept Therapeutics USD 9.64M 3.53M Mar/2026
Eli Lilly USD 43.37B 867M Mar/2026
Henry Schein USD 3.81B 64M Jun/2026
Idexx Laboratories USD 1.1B 9.37M Jun/2026
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Merck USD 49.12B 222M Mar/2026
Nektar Therapeutics USD 0 0 Jun/2022
Pacira USD 363.12M 4.53M Jun/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.05B 33.86M Mar/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Zoetis USD 9.24B 0 Mar/2026